cached image

Kai W. Wucherpfennig

Affiliations: 
Cancer Immunology and AIDS Dana-Farber Cancer Research Institute 
Area:
T Cell Biology and Cancer Immunology
Website:
http://www.fas.harvard.edu/~biophys/Kai_W_Wucherpfennig.htm
Google:
"Kai W. Wucherpfennig"
Bio:

http://www.dfhcc.harvard.edu/membership/profile/member/491/0/
http://researchers.dana-farber.org/directory/profile.asp?pict_id=0000124
http://dms.hms.harvard.edu/immunology/fac/Wucherpfennig.php
Kai W. Wucherpfennig received his M.D./Ph.D. degree from the University of Goettingen, Germany, and did postdoctoral work with Dr David Hafler at the Brigham and Women's Hospital and with Dr Jack Strominger at Harvard University before joining the faculty of the Dana-Farber Cancer Institute.

Mean distance: 17.02
 
SNBCP
Cross-listing: Neurotree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hara T, Chanoch-Myers R, Mathewson ND, et al. (2021) Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. Cancer Cell
Roehle K, Qiang L, Ventre KS, et al. (2021) cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytes. Science Translational Medicine. 13
Heckler M, Ali LR, Clancy-Thompson E, et al. (2021) Inhibition of CDK4/6 promotes CD8 T-cell memory formation. Cancer Discovery
Kumar S, Zeng Z, Bagati A, et al. (2021) CARM1 Inhibition Enables Immunotherapy of Resistant Tumors by Dual Action on Tumor cells and T cells. Cancer Discovery
Dougan M, Luoma AM, Dougan SK, et al. (2021) Understanding and treating the inflammatory adverse events of cancer immunotherapy. Cell. 184: 1575-1588
Frangieh CJ, Melms JC, Thakore PI, et al. (2021) Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion. Nature Genetics
Mathewson ND, Ashenberg O, Tirosh I, et al. (2021) Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis. Cell
Cartwright ANR, Suo S, Badrinath S, et al. (2021) Immunosuppressive Myeloid Cells Induce Nitric Oxide-dependent DNA Damage and p53 Pathway Activation in CD8+ T cells. Cancer Immunology Research
Jerby-Arnon L, Neftel C, Shore ME, et al. (2021) Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma. Nature Medicine
Hu Z, Leet DE, Allesøe RL, et al. (2021) Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma. Nature Medicine
See more...